Form 4: GAXOS.AI Director Feldman Receives Stock Option Grant
Insider Transaction Report
GAXOS.AI Director Roman Feldman was granted 25,000 employee stock options with an exercise price of $1.32, vesting on March 20, 2027.
Summary
- Roman Feldman, a Director and 10% Owner of GAXOS.AI INC. (GXAI), was granted 25,000 Employee Stock Options.
- The options have an exercise price of $1.32 per share.
- The grant date for these options was March 20, 2026.
- The options were issued under the Issuer's 2022 Equity Incentive Plan.
- One hundred percent (100%) of the shares subject to the option will vest on the one-year anniversary of the grant date, which is March 20, 2027.
- The options have an expiration date of March 20, 2031.
- Following this transaction, Roman Feldman beneficially owns 50,000 derivative securities directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued alignment of a key director's interests with long-term shareholder value, without indicating any immediate operational or financial changes.
Positives
- The grant of stock options aligns the interests of Director Roman Feldman with those of shareholders, incentivizing long-term company performance.
- The options were issued under an existing 2022 Equity Incentive Plan, indicating a structured approach to executive compensation.
Future Outlook
The options granted to Director Roman Feldman are scheduled to vest 100% on March 20, 2027, aligning future compensation with company performance over the next year.
Industry Context
StockSavvy.ai notes that the grant of stock options to a director is a standard practice in corporate governance, designed to align executive incentives with shareholder value creation. Such grants are common across various industries as a form of long-term equity compensation.
Comparison to Industry Standards
- Equity incentive plans, such as GAXOS.AI's 2022 plan, are a common mechanism for compensating directors and executives, comparable to practices at technology companies like Palantir Technologies Inc. (PLTR) or C3.ai, Inc. (AI) which also utilize stock-based compensation to attract and retain talent.
- The one-year cliff vesting schedule for 100% of the options is a typical vesting structure, often seen in early-stage or growth companies, similar to grants observed at emerging software firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 25,000 employee stock options to Director Roman Feldman under the existing 2022 Equity Incentive Plan. | 03/20/2026 | Enhances alignment of director's interests with shareholder value through performance-based equity. |
Related Party Transactions
- Grant of employee stock options to Roman Feldman, a Director and 10% Owner, which is a transaction between the company and an insider.
Stakeholder Impact
- Shareholders: Potential positive impact due to increased alignment of a director's incentives with long-term company performance.
- Employees: The grant is part of an equity incentive plan, which generally benefits employees by offering ownership stakes.
Next Steps
- Vesting of the 25,000 employee stock options on March 20, 2027.
- Potential exercise of options by Roman Feldman between March 20, 2027, and March 20, 2031.
Key Dates
| Date | Description |
|---|---|
| 03/20/2026 | Date of option grant |
| 03/20/2027 | Vesting date for 100% of the granted options |
| 03/20/2031 | Expiration date of the options |
Recommendation
holdThis Form 4 filing reports a routine grant of stock options to a director, which is a standard compensation practice aimed at aligning management interests with shareholders. It does not contain new financial performance data, strategic shifts, or significant insider buying/selling activity that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide a basis for a strong buy or sell decision.
Keywords
GAXOS.AI, GXAI, Roman Feldman, stock options, equity grant, insider transaction, Form 4, director compensation, equity incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.